Starsource Multitrade Limited, formerly Chemo Pharma Laboratories Limited, is an India-based company. The Company was engaged in manufacturing operations. It has no operations and does not generate any revenue. The Company is exploring new business opportunities.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
10/26/10	₹73.49	-2.74%	144
09/26/09	₹75.56	-2.79%	3
08/26/08	₹77.73	-1.71%	22
07/26/07	₹79.08	-0.73%	53
04/26/04	₹79.66	-0.88%	279

Delayed Quote Bombay S.E.

More quotes

Market Closed - Bombay S.E. 03:33:24 10/09/2026 pm IST			5-day change	1st Jan Change
73.49 ^INR	-2.74%		-10.44%	-35.93%

14/08	Starsource Multitrade Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
29/05	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	11Cr 11.53L 10L 9L 9L 15.93L 16.08L 1.11Cr 42.88L 5.59Cr 43.3L 42.35L 18Cr	P/E 2025	54.6x	P/E 2026	-1.41x
Enterprise Value	9.71Cr 10.15L 9L 8L 8L 14.03L 14.16L 98.12L 37.76L 4.92Cr 38.13L 37.29L 16Cr	EV / Sales 2025	13x	EV / Sales 2026	28x
Free-Float	61.17%	Yield 2025 *	-	Yield 2026	-

14/08	Starsource Multitrade Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
29/05	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
12/02	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
14/11	Starsource Multitrade Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
01/25/01	Chemo Pharma Laboratories Limited has Changed its Name to Starsource Multitrade Limited	CI
25/25/25	Chemo Pharma Laboratories Limited Announces Changes to Its Board	CI
25/25/25	Chemo Pharma Laboratories Limited Appoints and Regularize Utsav Trivedi as CFO	CI
25/25/25	Chemo Pharma Laboratories Limited Appoints and Regularize Ruchit Mehta as Chief Executive Officer	CI
12/25/12	Chemo Pharma Laboratories Limited Announces Company Secretary and Compliance Officer, Effective from September 12, 2025	CI
12/25/12	Chemo Pharma Laboratories Limited Decides to Shift the Registered Office	CI
12/25/12	Chemo Pharma Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
29/25/29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
27/25/27	Chemo Pharma Laboratories to Open New Corporate Office in Ahmedabad, India; Shares Down 4%	MT

1 day	-2.74%
1 week	-10.44%
Current month	-13.34%
1 month	-0.20%
3 months	-35.51%
6 months	-15.21%
Current year	-35.93%

Starsource Multitrade Limited Share Price

Stocks

CHEMOPH6

INE320M01019

Investment Holding Companies

Valuation : Starsource Multitrade Limited

Chart: Starsource Multitrade Limited

Latest news : Starsource Multitrade Limited

Quotes and Performance

Price Extremes

Managers and Directors : Starsource Multitrade Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	73.05	84.35
1 month	73.05	95
Current year	72	152.9
1 year	72	152.9
3 years	28	154
5 years	22.7	154
10 years	5.45	154

Manager	Title	Age	Since
Ruchit Mehta CEO	Chief Executive Officer	35	16/04/2025
Utsav Trivedi DFI	Director of Finance/CFO	27	16/04/2025
Aditya Agarwal CMP	Compliance Officer	-	12/09/2025

Director	Title	Age	Since
Simran Ankleshwar Tripathi BRD	Director/Board Member	-	31/12/2024
Ruchit Mehta BRD	Director/Board Member	35	16/04/2025
Simran Utsav Trivedi BRD	Director/Board Member	30	31/12/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STARSOURCE MULTITRADE LIMITED	-2.74%	-10.44%	-35.56%	+128.94%	11.91L
CHURCHILL CAPITAL CORP XI	-2.95%	-3.39%	-	-	74Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	0.00%	-	-	65Cr
BAIN CAPITAL GSS INVESTMENT CORP.	+0.10%	+0.19%	-	-	60Cr
CENTIEL AG	-0.69%	+7.92%	+240.48%	-78.81%	58Cr
CHURCHILL CAPITAL CORP XII	-0.18%	-0.41%	-	-	60Cr
CANTOR EQUITY PARTNERS IV, INC.	-0.14%	-0.34%	+2.12%	-	59Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.26%	-1.64%	-	-	56Cr
CHURCHILL CAPITAL CORP XIII	-0.38%	-0.66%	-	-	51Cr
Average	-0.85%	-0.25%	+69.01%	+25.06%	53.63Cr
Weighted average by Cap.	-0.68%	+0.67%	+119.87%	-78.39%

	2025	2026
Net sales	61.98L 64.83T 55.76T 52.61T 47.92T 89.59T 90.4T 6L 2L 31.44L 2L 2L 99.86L	54.95L 57.48T 49.43T 46.64T 42.49T 79.43T 80.15T 6L 2L 27.87L 2L 2L 88.53L
Net income	34.22L 35.79T 30.78T 29.04T 26.46T 49.46T 49.91T 3L 1L 17.36L 1L 1L 55.13L	-12Cr -12.4L -10.66L -10.06L -9L -17.13L -17.29L -1.2Cr -46.12L -6.01Cr -46.56L -45.54L -19Cr
Net Debt	-11Cr -11.11L -10L -9L -8L -15.35L -15.49L -1.07Cr -41.32L -5.39Cr -41.72L -40.81L -17Cr	-1.32Cr -1L -1L -1L -1L -2L -2L -13.3L -5L -66.76L -5L -5L -2.12Cr